The Clorox Company $CLX Stock Position Lifted by Simplicity Wealth LLC

Key Points

• Simplicity Wealth LLC increased its stake in The Clorox Company by 157.3% in Q2, owning 18,316 shares valued at approximately $2.2 million.
• Insider COO Eric H. Reynolds sold 15,041 shares in September, decreasing his ownership by 21.72%.
• Clorox reported earnings of $2.87 per share for the last quarter, surpassing estimates and showing a 4.5% year-over-year revenue increase.

Simplicity Wealth LLC grew its position in The Clorox Company (NYSE:CLX - Free Report) by 157.3% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 18,316 shares of the company's stock after acquiring an additional 11,198 shares during the quarter. Simplicity Wealth LLC's holdings in Clorox were worth $2,199,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. American National Bank & Trust lifted its position in shares of Clorox by 69.5% in the 2nd quarter. American National Bank & Trust now owns 217 shares of the company's stock worth $26,000 after buying an additional 89 shares during the last quarter. Ransom Advisory Ltd acquired a new stake in Clorox during the first quarter worth about $35,000. GW&K Investment Management LLC lifted its holdings in Clorox by 239.1% in the first quarter. GW&K Investment Management LLC now owns 295 shares of the company's stock worth $43,000 after acquiring an additional 208 shares during the last quarter. Ameritas Advisory Services LLC acquired a new position in Clorox in the second quarter valued at approximately $48,000. Finally, Roble Belko & Company Inc boosted its stake in Clorox by 140.7% in the first quarter. Roble Belko & Company Inc now owns 361 shares of the company's stock valued at $53,000 after acquiring an additional 211 shares during the period. 78.53% of the stock is currently owned by institutional investors.

Insider Activity at Clorox

In related news, COO Eric H. Reynolds sold 15,041 shares of the stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the sale, the chief operating officer directly owned 54,221 shares of the company's stock, valued at $6,711,475.38. This represents a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.57% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on CLX. Wells Fargo & Company dropped their target price on Clorox from $130.00 to $125.00 and set an "equal weight" rating on the stock in a research report on Thursday, September 25th. JPMorgan Chase & Co. increased their price objective on shares of Clorox from $133.00 to $135.00 and gave the stock a "neutral" rating in a report on Monday, September 8th. UBS Group reduced their target price on shares of Clorox from $150.00 to $134.00 and set a "neutral" rating for the company in a research note on Thursday, July 17th. Barclays dropped their price target on shares of Clorox from $118.00 to $112.00 and set an "underweight" rating on the stock in a research note on Tuesday, September 30th. Finally, Citigroup reaffirmed a "neutral" rating and set a $135.00 price target (down previously from $140.00) on shares of Clorox in a report on Tuesday, July 15th. One equities research analyst has rated the stock with a Buy rating, ten have issued a Hold rating and three have assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, Clorox has a consensus rating of "Reduce" and an average price target of $134.08.

Clorox Trading Up 0.9%

Clorox stock opened at $123.30 on Monday. The Clorox Company has a 12-month low of $116.53 and a 12-month high of $171.37. The stock has a market capitalization of $15.08 billion, a PE ratio of 18.91, a price-to-earnings-growth ratio of 1.00 and a beta of 0.52. The firm has a 50 day simple moving average of $122.81 and a 200-day simple moving average of $129.41. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.24 by $0.63. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The firm had revenue of $1.99 billion during the quarter, compared to analyst estimates of $1.94 billion. During the same period last year, the company posted $1.82 EPS. The firm's quarterly revenue was up 4.5% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, equities research analysts expect that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd will be paid a $1.24 dividend. The ex-dividend date of this dividend is Wednesday, October 22nd. This represents a $4.96 annualized dividend and a dividend yield of 4.0%. Clorox's payout ratio is currently 76.07%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.